Hydrogenation of CO2 to form methanol utilizing green hydrogen is a promising route to realizing carbon neutrality. However, the development of catalyst with high activity and selectivity to methanol from the CO2 hydrogenation is still a challenge due to the chemical inertness of CO2 and its characteristics of multi-path conversion. Herein, a series of highly active carbon-confining molybdenum sulfide (MoS2@C) catalysts were prepared by the in-situ pyrolysis method. In comparison with the bulk MoS2 and MoS2/C, the stronger interaction between MoS2 and the carbon layer was clearly generated. Under the optimized reaction conditions, MoS2@C showed better catalytic performance and long-term stability. The MoS2@C catalyst could sustain around 32.4% conversion of CO2 with 94.8% selectivity of MeOH for at least 150 h.
In
the processes of hydrogenation, the accurate control of product
distribution is crucial to the high-value conversion of furfural.
Herein, Ni3P catalysts were prepared by phase separation
synthesis with porous hollow nanospheres and employed as catalysts
for the hydrogenation of furfural. Over the Ni3P-400 catalyst,
furfural could be transformed completely with 95.6% selectivity toward
furfuryl alcohol under 120 °C and 1.6 MPa for 4 h. The deactivation
of the Ni3P-400 catalyst was not observed during 8-run
recycling tests. Moreover, using other carbonyl compounds derived
from biomass as substrates, excellent catalytic performance was also
obtained. Such exceptional features make the Ni3P-400 catalyst
promising for industrial applications not only in hydrogenation of
furfural but also in hydrogenation of other carbonyl substrates.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.